Hyundai Bioscience Initiates Global Clinical Trials for Dengue Antiviral, Pursuing Emergency Use Authorization
SEOUL, South Korea, April 19, 2024 -- South Korea's biotechnology company Hyundai Bioscience announced on April 15 that it would carry out global clinical tests aimed...